|
Subsequent events (Details) (USD $)
|
12 Months Ended | 2 Months Ended | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
Dec. 31, 2013
Cangene [Member]
|
Dec. 31, 2012
Cangene [Member]
|
Feb. 21, 2014
Subsequent Event [Member]
Cangene [Member]
|
Feb. 21, 2014
Subsequent Event [Member]
Cangene [Member]
Corporate Trade Name [Member]
|
Feb. 21, 2014
Subsequent Event [Member]
Cangene [Member]
Marketed Products [Member]
|
Feb. 21, 2014
Subsequent Event [Member]
Cangene [Member]
Licensed Products [Member]
|
Feb. 21, 2014
Subsequent Event [Member]
Cangene [Member]
Biodefense [Member]
|
Feb. 21, 2014
Subsequent Event [Member]
Cangene [Member]
Contract Manufacturing [Member]
|
Feb. 21, 2014
Subsequent Event [Member]
Cangene [Member]
Fair Value Adjustment to Inventory [Member]
|
||||
| Subsequent Event [Line Items] | |||||||||||||||
| Price per share (in dollars per share) | $ 3.24 | ||||||||||||||
| Estimated fair value of tangible assets acquired and liabilities assumed: | |||||||||||||||
| Acquired tangible assets (1) | $ 202,500,000 | [1] | |||||||||||||
| Assumed tangible liabilities | (38,300,000) | ||||||||||||||
| Total estimated fair vlaue of tangible assets acquired and liabilities assumed | 164,200,000 | ||||||||||||||
| Identified intangible assets | 52,500,000 | 2,600,000 | 5,100,000 | 1,900,000 | 34,400,000 | 8,500,000 | |||||||||
| Deferred tax liability associated with intangible assets | (3,000,000) | ||||||||||||||
| Identified intangible assets, net of associated deferred taxes | 49,500,000 | ||||||||||||||
| Goodwill | 13,954,000 | 5,502,000 | 5,502,000 | 8,300,000 | |||||||||||
| Total preliminary estimated purchase price | 222,000,000 | ||||||||||||||
| Intangible Assets Acquired [Abstract] | |||||||||||||||
| Finite-Lived Intangible Asset, Useful Life | 5 years | 15 years | 3 years | 15 years | 15 years | ||||||||||
| Step up adjustment to inventory | 12,300,000 | ||||||||||||||
| Amortization period of step up adjustment | 5 years | ||||||||||||||
| Transaction costs | 3,300,000 | ||||||||||||||
| Business Acquisition, Pro Forma Information [Abstract] | |||||||||||||||
| Pro forma revenue | 440,320,000 | 400,269,000 | |||||||||||||
| Pro forma net income | $ 13,914,000 | $ 2,171,000 | |||||||||||||
|
|||||||||||||||